Cognoa

FDA-authorized AI diagnostic aid for autism in children

What It Does

Cognoa's Canvas Dx is the first FDA-authorized AI tool aiming to help physicians diagnose autism faster in young children.

AI Features (Expert Assessment)

Cognoa's Canvas Dx leverages proprietary machine learning algorithms trained on expansive clinical datasets to identify predictive behavioral markers of autism in young children. The system processes multimodal inputs through its model to purely aid human physicians in generating a diagnosis.

Who Is This For?

Pediatricians and parents seeking early diagnosis.

Pros

  • ✓ FDA authorized
  • ✓ Reduces waitlist times theoretically

Cons

  • ✗ Not a standalone diagnosis tool
  • ✗ Limited age range